Mediwound LtdNASDAQ:MDWD
- LAST PRICE17.3300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots16.8000/ 1
- Ask / Lots17.9700/ 1
- Open / Previous Close--- / 17.3300
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MDWD |
|---|---|---|
| 09:32 ET | 3222 | 16.2995 |
| 09:33 ET | 200 | 16.48 |
| 09:44 ET | 470 | 16.5 |
| 09:46 ET | 500 | 16.5 |
| 09:48 ET | 2000 | 16.59 |
| 09:50 ET | 100 | 16.47 |
| 09:51 ET | 1200 | 16.3401 |
| 09:53 ET | 100 | 16.315 |
| 10:13 ET | 700 | 16.5025 |
| 10:15 ET | 700 | 16.52 |
| 10:18 ET | 797 | 16.45 |
| 10:20 ET | 100 | 16.64 |
| 10:24 ET | 598 | 16.75 |
| 10:27 ET | 2303 | 16.81 |
| 10:38 ET | 100 | 16.75 |
| 10:44 ET | 1000 | 16.81 |
| 10:51 ET | 200 | 16.81 |
| 10:54 ET | 2000 | 16.81 |
| 10:58 ET | 500 | 16.7 |
| 11:00 ET | 179 | 16.735 |
| 11:07 ET | 100 | 16.68 |
| 11:23 ET | 165 | 16.735 |
| 11:25 ET | 1891 | 16.62 |
| 11:32 ET | 100 | 16.65 |
| 11:36 ET | 1931 | 16.58 |
| 11:41 ET | 700 | 16.7215 |
| 11:54 ET | 1086 | 16.6456 |
| 11:56 ET | 100 | 16.63 |
| 11:59 ET | 340 | 16.734 |
| 12:01 ET | 100 | 16.68 |
| 12:10 ET | 200 | 16.62 |
| 12:39 ET | 350 | 16.51 |
| 12:42 ET | 277 | 16.45 |
| 12:51 ET | 100 | 16.53 |
| 12:53 ET | 800 | 16.485 |
| 12:55 ET | 200 | 16.485 |
| 12:57 ET | 600 | 16.6 |
| 01:00 ET | 1302 | 16.74 |
| 01:06 ET | 500 | 16.81 |
| 01:15 ET | 200 | 16.82 |
| 01:22 ET | 348 | 16.8 |
| 01:29 ET | 310 | 16.805 |
| 01:31 ET | 100 | 16.67 |
| 01:42 ET | 100 | 16.82 |
| 02:03 ET | 200 | 16.85 |
| 02:07 ET | 645 | 17 |
| 02:18 ET | 300 | 17.08 |
| 02:20 ET | 200 | 17.2 |
| 02:21 ET | 100 | 17.15 |
| 02:32 ET | 200 | 17.2 |
| 02:34 ET | 100 | 17.2 |
| 02:45 ET | 100 | 17.1815 |
| 02:50 ET | 500 | 17.19 |
| 03:01 ET | 560 | 17.25 |
| 03:03 ET | 651 | 17.25 |
| 03:17 ET | 2029 | 17.161 |
| 03:24 ET | 100 | 17.175 |
| 03:30 ET | 804 | 17.01 |
| 03:33 ET | 717 | 17.07 |
| 03:35 ET | 200 | 17.11 |
| 03:37 ET | 292 | 17.13 |
| 03:39 ET | 100 | 17.1 |
| 03:44 ET | 395 | 17.12 |
| 03:46 ET | 1524 | 17.29 |
| 03:48 ET | 200 | 17.35 |
| 03:53 ET | 210 | 17.2574 |
| 03:55 ET | 100 | 17.325 |
| 03:57 ET | 544 | 17.3 |
| 04:00 ET | 1652 | 17.33 |
Nov 12, 2024
MediWound to Report Third Quarter 2024 Financial Results, from 8:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
8:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mediwound Ltd | 177.8M | -8.0x | --- |
TriSalus Life Sciences Inc | 132.8M | -2.4x | --- |
Fennec Pharmaceuticals Inc | 145.9M | -56.4x | --- |
Elutia Inc | 142.4M | -2.0x | --- |
TScan Therapeutics Inc | 240.7M | -4.3x | --- |
Nanobiotix SA | 172.8M | -3.0x | --- |
Company Information
Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues.; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.
Contact Information
- Headquarters
- 42 Hayarkon StreetYAVNE, Israel 8122745
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Nachum Shamir
- Chief Executive Officer, Director
- Ofer Gonen
- Chief Financial Officer
- Hani Luxenburg
- Chief Operating Officer, Chief Commercial Officer
- Shmulik Hess
- Executive Vice President, General Counsel, Corporate Secretary
- Yaron Meyer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $177.8M |
|---|---|
Revenue (TTM) | $20.1M |
Shares Outstanding | 10.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.82 |
EPS | $-2.16 |
Book Value | $3.43 |
P/E Ratio | -8.0x |
Price/Sales (TTM) | 8.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -75.16% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
